C1q DEFICIENCY
|
disease |
|
Disease or Syndrome
|
5
|
8
|
0.610 |
strong |
1.000 |
2 |
2
|
2012 |
2017 |
SYSTEMIC LUPUS ERYTHEMATOSUS 16
|
disease |
|
Disease or Syndrome
|
5
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Lupus anticoagulant measurement
|
phenotype |
|
Laboratory Procedure
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Decreased serum complement C4
|
phenotype |
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Lupus anticoagulant -- finding
|
phenotype |
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Membranoproliferative Glomerulonephritis, Type III
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
1996 |
1996 |
Urine looks dark
|
phenotype |
|
Finding
|
6
|
|
0.100 |
None |
|
0 |
|
|
|
Membranoproliferative Glomerulonephritis, Type I
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
1996 |
1996 |
Decreased serum complement factor I
|
phenotype |
|
Finding
|
7
|
|
0.100 |
None |
|
0 |
|
|
|
Late onset neutropenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
9
|
3
|
0.010 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Immune Complex Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
10
|
|
0.300 |
None |
1.000 |
1 |
|
1996 |
1996 |
Membranoproliferative Glomerulonephritis, Type II
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
10
|
3
|
0.300 |
None |
1.000 |
1 |
|
1996 |
1996 |
Decreased serum complement C3
|
phenotype |
|
Finding
|
12
|
|
0.100 |
None |
|
0 |
|
|
|
Other specified iron deficiency anemias
|
disease |
Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
13
|
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Butterfly rash
|
phenotype |
Skin and Connective Tissue Diseases
|
Finding
|
13
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the gastrointestinal tract
|
phenotype |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases
|
Anatomical Abnormality
|
14
|
1
|
0.100 |
None |
|
0 |
|
|
|
Antineutrophil antibody positivity
|
phenotype |
|
Laboratory or Test Result
|
15
|
|
0.100 |
None |
|
0 |
|
|
|
Antiphospholipid antibody positivity
|
phenotype |
|
Finding
|
18
|
|
0.100 |
None |
|
0 |
|
|
|
Increased lactate dehydrogenase activity
|
phenotype |
|
Finding
|
27
|
|
0.100 |
None |
|
0 |
|
|
|
Microangiopathic hemolytic anemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
31
|
|
0.100 |
None |
|
0 |
|
|
|
Anti-nuclear factor positive
|
phenotype |
Skin and Connective Tissue Diseases
|
Laboratory or Test Result
|
35
|
3
|
0.100 |
None |
|
0 |
|
|
|
Disturbance of consciousness
|
phenotype |
|
Finding
|
35
|
|
0.100 |
None |
|
0 |
|
|
|
ESR raised
|
phenotype |
|
Finding
|
36
|
|
0.100 |
None |
|
0 |
|
|
|
Lupus Erythematosus, Cutaneous
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
39
|
7
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Lupus Erythematosus, Subacute Cutaneous
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
39
|
1
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |